Industry News
Smart use for wisdom teeth
The mesenchymal stromal cells in wisdom teeth pulp can be used to create lines of induced-pluripotent stem cells - opening up a new potential avenue for stem-cell therapy whereby patients could be treated with their own stem cells.
[ + ]Market report: ASX down slightly despite another rally on Wall Street overnight
The Australian Stock Market just managed to stayed ahead for the week this week, as weakness from major sectors pushed down on the market. [ + ]
Universal Biosensors poised for sale
The retirement this week of Mark Morrisson as the CEO of Australian medical diagnostics company Universal Biosensors has triggered speculation throughout the industry that the company may be on the market. [ + ]
Top Qld researcher receives funding boost for leukaemia work
Professor Geoff Hill, chair of immunology at the Queensland Institute of Medical Research (QIMR), has been awarded a second round Senior Clinical Research Fellowships (SCRF) from the Queensland Government to support his work on improving bone marrow transplant success for leukaemia sufferers. [ + ]
Novogen to sell isoflavone portfolio to Marshall Edwards
Australian drug development company Novogen announced today that it has agreed to sell the rights to its entire isoflavone portfolio to US subsidiary Marshall Edwards in return for stock. [ + ]
Long-term study on childhood cancer released
It wasn’t so long ago that a diagnosis of cancer in children was an almost certain death sentence. Nowadays more than 80 percent of affected children survive into later life and beyond. However, with this greater life expectancy comes an increased risk of a recurrance of the initial cancer, secondary cancers and a host of other debilitating health conditions. [ + ]
Stem cell funding ban upheld in the US
A U.S judge is refusing to yield to pressure to reverse a ban issued last month on funding for human embryonic stem cell research which the Obama administration says is putting millions of dollars of federal funding and some 1300 jobs at risk, the New York Times reports. [ + ]
Feature: Proteomics power of pawpaw
It may sound like the spiel of a snake-oil salesman, but the story behind the development of a new Australian product derived from an extract of pawpaw (Carica papaya) designed to promote wound healing is a compelling one. The Australian company behind it, Phoenix Eagle, has developed a new product, OPAL A, that could revolutionise wound healing and wound care. [ + ]
European researchers report major new malaria breakthrough
European researchers have identified an exciting new drug candidate which has shown to be effective against common malaria parasites including drug-resistant strains of the virus. [ + ]
Market report: ASX posts strong week following robust economic data
The Australian Stock Market finished up for the week today, ending several weeks of losses, as investors warmed to the positive outlook for the local economy. [ + ]
Drug screening robot comes to the rescue for kids with cancer
The Children’s Cancer Institute Australia for Medical Research (CCIA) has received $3.1 million to fund a new drug screening robot designed to radically improve the understanding and treatment of cancer in children. [ + ]
Dr Christine Bennett named new chair of Research Australia
Research Australia today announced the appointment of Dr Christine Bennett as its new chair. [ + ]
Study links metals imbalance with Alzheimer’s
Scientists from Australia and the US have published the results of a study linking an imbalance of metals in the brain with Alzheimer's disease. [ + ]
Researchers find migraine gene
An international group of researchers has identified what might be the first known genetic indicator for migraine risk. [ + ]
